Case Report
Published on 21 Jan 2025
Case report: Near-complete response to neratinib-based treatment in HR-positive HER2-amplified metastatic breast cancer refractory to trastuzumab deruxtecan
- 4,456 views
- 2 citations
Case Report
Published on 21 Jan 2025
Original Research
Published on 21 Jan 2025
Case Report
Published on 21 Jan 2025
Case Report
Published on 21 Jan 2025
Original Research
Published on 21 Jan 2025
Systematic Review
Published on 21 Jan 2025
Original Research
Published on 21 Jan 2025
Case Report
Published on 21 Jan 2025
Original Research
Published on 21 Jan 2025
Mini Review
Published on 21 Jan 2025
Original Research
Published on 21 Jan 2025
Original Research
Published on 21 Jan 2025
Review
Published on 21 Jan 2025
Original Research
Published on 21 Jan 2025
Original Research
Published on 21 Jan 2025
Review
Published on 21 Jan 2025
Original Research
Published on 20 Jan 2025
Original Research
Published on 20 Jan 2025
Review
Published on 20 Jan 2025
Review
Published on 20 Jan 2025
Original Research
Published on 20 Jan 2025
Original Research
Published on 20 Jan 2025
Review
Published on 20 Jan 2025
Original Research
Published on 20 Jan 2025